Thyroid cancer
Conditions
Interventions
Experimental group:Orally administered Prunella vulgaris Paste
Control group:placebo
Sponsors
The 960th Hospital of the People's Liberation Army
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1) Age = 75 years old, and pathologically diagnosed with intermediate- to high-risk papillary thyroid carcinoma after surgery; 2) Undergoing routine TSH suppression therapy for more than 1 month after surgery, with the TSH suppression target set below the normal level; 3) All underwent conventional open surgery;
Exclusion criteria
Exclusion criteria: 1) Patients with severe systemic diseases such as liver, kidney, cardiovascular, cerebrovascular, or skeletal diseases, or with psychiatric disorders; 2) Patients allergic to any component of Prunella vulgaris Paste; 3) Pregnant or lactating women; 4) Patients currently participating in other clinical drug trials; 5) Patients who do not sign the informed consent form.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TCM Efficacy and Syndrome Score Sheet; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of Life Assessment Scale;Thyroid Function; | — |
Countries
CHINA
Contacts
Public ContactQingqing HE
The 960th Hospital of the People's Liberation Army
Outcome results
None listed